The present invention provides compositions and methods for down-modulating the expression and/or the immuno-suppressive activity of i) the FMRP protein, ii) an mRNA encoding the FMRP protein, and/or iii) the FMR1 gene for the treatment and/or prevention of primary cancer and/or cancer metastasis in a subject in need thereof.
Type
patent
EPO Family ID
66439945
Author(s)
Note
Alternative title(s) : (en) Fmrp and cancer treatment
TTO classification
TTO:6.1928
| Identifier | Country code | Kind code | Date issued |
US2023227823 | US | A1 | 2023-07-20 |
US11473087 | US | B2 | 2022-10-18 |
JP2022532303 | JP | A | 2022-07-14 |
EP3966326 | EP | A1 | 2022-03-16 |
CN113784731 | CN | A | 2021-12-10 |
AU2020269398 | AU | A1 | 2021-11-25 |
CA3137667 | CA | A1 | 2020-11-12 |
US2020354718 | US | A1 | 2020-11-12 |
WO2020225309 | WO | A1 | 2020-11-12 |
Available on Infoscience
December 2, 2020
Use this identifier to reference this record